CN109476678B - Heterocyclic compound and organic light-emitting element comprising same - Google Patents

Heterocyclic compound and organic light-emitting element comprising same Download PDF

Info

Publication number
CN109476678B
CN109476678B CN201880002765.5A CN201880002765A CN109476678B CN 109476678 B CN109476678 B CN 109476678B CN 201880002765 A CN201880002765 A CN 201880002765A CN 109476678 B CN109476678 B CN 109476678B
Authority
CN
China
Prior art keywords
group
compound
chemical formula
present specification
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201880002765.5A
Other languages
Chinese (zh)
Other versions
CN109476678A (en
Inventor
金永锡
权赫俊
金旼俊
金公谦
金正凡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LG Chem Ltd
Original Assignee
LG Chem Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LG Chem Ltd filed Critical LG Chem Ltd
Publication of CN109476678A publication Critical patent/CN109476678A/en
Application granted granted Critical
Publication of CN109476678B publication Critical patent/CN109476678B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/14Carrier transporting layers
    • H10K50/15Hole transporting layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/14Carrier transporting layers
    • H10K50/16Electron transporting layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/17Carrier injection layers
    • H10K50/171Electron injection layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1044Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
    • C09K2211/1048Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms with oxygen
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1044Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
    • C09K2211/1051Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms with sulfur
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers

Abstract

The present specification relates to a heterocyclic compound represented by chemical formula 1 and an organic light emitting element including the same.

Description

Heterocyclic compound and organic light-emitting element comprising same
Technical Field
The present application claims priority to korean patent application No. 10-2017-0019961, filed on 14.2.2017 from the korean patent office, the contents of which are incorporated herein in their entirety.
The present specification relates to a heterocyclic compound and an organic light-emitting element including the same.
Background
In general, the organic light emitting phenomenon refers to a phenomenon of converting electric energy into light energy using an organic substance. An organic light emitting element utilizing an organic light emitting phenomenon generally has a structure including an anode and a cathode with an organic layer interposed therebetween. In order to improve the efficiency and stability of the organic light-emitting device, the organic layer is often composed of a multilayer structure composed of different materials, and the multilayer structure may be formed of, for example, a hole injection layer, a hole transport layer, a light-emitting layer, an electron transport layer, an electron injection layer, or the like. In the structure of such an organic light emitting element, if a voltage is applied between the electrodes, holes are injected from the anode into the organic layer, electrons are injected from the cathode into the organic layer, excitons (exiton) are formed when the injected holes and electrons meet each other, and light is emitted when the excitons are transitioned to the ground state again.
There is a continuing need to develop new materials for the above-described organic light emitting elements.
Disclosure of Invention
The present specification provides a heterocyclic compound and an organic light-emitting element including the same.
According to one embodiment of the present specification, there is provided a heterocyclic compound represented by the following chemical formula 1.
[ chemical formula 1]
Figure GDA0002886626150000021
In the chemical formula 1 described above,
x1 is O or S,
l1 is a direct bond, a substituted or unsubstituted arylene, or a substituted or unsubstituted heteroarylene,
y1 and Y3 are N, Y2 is CR13 and Y4 is CR14, or Y2 and Y4 are N, Y1 is CR14 and Y3 is CR13,
r13 represents a group bonded to L1,
r2 and R3, or R3 and R4 are groups bound to the atom of the following chemical formula 2,
the group not bonded to the group of chemical formula 2, R1, R5 to R12 and R14, which are the same or different from each other, of R2 to R4, are each independently hydrogen, a substituted or unsubstituted aryl group, or a substituted or unsubstituted heteroaryl group, or adjacent groups may be bonded to each other to form a substituted or unsubstituted ring,
n is 1 or 2, and n is a hydrogen atom,
when n is 2, two L1 are the same as or different from each other,
[ chemical formula 2]
Figure GDA0002886626150000022
In the chemical formula 2 described above, the,
is a site binding to R2 and R3, or R3 and R4 of the above chemical formula 1,
ar1 is a substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl,
r15 to R18 are the same as or different from each other, and each is independently hydrogen, a substituted or unsubstituted aryl group, or a substituted or unsubstituted heteroaryl group, or adjacent groups may be bonded to each other to form a substituted or unsubstituted ring.
In addition, according to one embodiment of the present specification, there is provided an organic light-emitting element including: the organic light emitting device includes a first electrode, a second electrode provided to face the first electrode, and 1 or more organic layers provided between the first electrode and the second electrode, wherein 1 or more of the organic layers include a heterocyclic compound represented by the chemical formula 1.
The heterocyclic compound according to one embodiment of the present specification can be used as a material for an organic layer of an organic light-emitting element, and by using the heterocyclic compound, improvement in efficiency, lower driving voltage, and/or improvement in lifetime characteristics can be achieved in the organic light-emitting element.
Drawings
Fig. 1 illustrates an organic light emitting element 10 according to an embodiment of the present description.
Fig. 2 illustrates an organic light emitting element 11 according to another embodiment of the present specification.
FIG. 3 is a mass spectrum of Compound 1 produced in Synthesis example 1 of the present specification.
FIG. 4 is a mass spectrum of Compound 2 produced in Synthesis example 2 of the present specification.
FIG. 5 is a mass spectrum of Compound 3 produced in Synthesis example 3 of the present specification.
FIG. 6 is a mass spectrum of Compound 4 produced in Synthesis example 4 of the present specification.
FIG. 7 is a mass spectrum of Compound 5 produced in Synthesis example 5 of the present specification.
FIG. 8 is a mass spectrum of Compound 6 produced in Synthesis example 6 of the present specification.
FIG. 9 is a mass spectrum of Compound 7 produced in Synthesis example 7 of the present specification.
FIG. 10 is a mass spectrum of Compound 8 produced in Synthesis example 8 of the present specification.
FIG. 11 is a mass spectrum of Compound 9 produced in Synthesis example 9 of the present specification.
FIG. 12 is a mass spectrum of Compound 10 produced in Synthesis example 10 of the present specification.
FIG. 13 is a mass spectrum of Compound 11 produced in Synthesis example 11 of the present specification.
FIG. 14 is a mass spectrum of Compound 12 produced in Synthesis example 12 of the present specification.
FIG. 15 is a mass spectrum of Compound 13 produced in Synthesis example 13 of the present specification.
FIG. 16 is a mass spectrum of Compound 14 produced in Synthesis example 14 of the present specification.
FIG. 17 is a mass spectrum of Compound 15 produced in Synthesis example 15 of the present specification.
FIG. 18 is a mass spectrum of Compound 16 produced in Synthesis example 16 of the present specification.
FIG. 19 is a mass spectrum of Compound 17 produced in Synthesis example 17 of the present specification.
FIG. 20 is a mass spectrum of Compound 18 produced in Synthesis example 18 of the present specification.
FIG. 21 is a mass spectrum of Compound 19 produced in Synthesis example 19 of the present specification.
FIG. 22 is a mass spectrum of Compound 20 produced in Synthesis example 20 of the present specification.
Fig. 23 is a mass spectrum of compound 21 produced in synthesis example 21 of the present specification.
FIG. 24 is a mass spectrum of Compound 22 produced in Synthesis example 22 herein.
FIG. 25 is a mass spectrum of Compound 23 produced in Synthesis example 23 of the present specification.
FIG. 26 is a mass spectrum of Compound 24 produced in Synthesis example 24 of the present specification.
Description of the symbols
10. 11: organic light emitting element
20: substrate
30: a first electrode
40: luminescent layer
50: second electrode
60: hole injection layer
70: hole transport layer
80: electron transport layer
90: electron injection layer
Detailed Description
The present specification will be described in more detail below.
The present specification provides heterocyclic compounds represented by the above chemical formula 1.
The heterocyclic compound represented by the above chemical formula 1 according to one embodiment of the present description has a structure in which the 2-position of benzofuran [3,4-d ] pyrimidine, benzofuran [2,3-d ] pyrimidine, benzothieno [3,4-d ] pyrimidine, or benzothieno [2,3-d ] pyrimidine is bonded to N of indolocarbazole through L1, and thus the flow of electrons is smooth, and the above chemical formula 2 is bonded to R2 and R3, or R3 and R4 in the above chemical formula 1, and thus the steric hindrance (steric hindrance) of the above chemical formula 1 is reduced and the structure is stabilized, so that the organic light-emitting element including the above chemical formula 1 has a low driving voltage, excellent efficiency, and a long lifetime.
In the present specification, when a part is referred to as "including" a certain component, unless specifically stated to the contrary, it means that the other component may be further included, and the other component is not excluded.
In the present specification, when a member is referred to as being "on" another member, it includes not only a case where the member is in contact with the another member but also a case where the another member is present between the two members.
Examples of the substituent in the present specification will be described below, but the present invention is not limited thereto.
The term "substituted" means that a hydrogen atom bonded to a carbon atom of a compound is replaced with another substituent, and the substituted position is not limited as long as the hydrogen atom can be substituted, that is, the substituted position of the substituent is substitutable, and when 2 or more substituents are substituted, 2 or more substituents may be the same as or different from each other.
The term "substituted or unsubstituted" in the present specification means substituted or unsubstituted with one or more groups selected from deuterium, a halogen group, a nitrile group, a nitro group, an imide group, an amide group, a carbonyl group, an ester group, a hydroxyl group, a substituted or unsubstituted alkyl group, a substituted or unsubstituted cycloalkyl group, a substituted or unsubstituted alkoxy group, a substituted or unsubstituted aryloxy group, a substituted or unsubstituted alkylthio group(s) ((s))
Figure GDA0002886626150000051
Alkyl thioaxy), substituted or unsubstituted arylthio(s) ((R)
Figure GDA0002886626150000052
Aryl thio), substituted or unsubstituted alkyl sulfoxide group(s) ((s)
Figure GDA0002886626150000053
Alkyl sulfoxy), a substituted or unsubstituted arylsulfoxide group(s) ((s)
Figure GDA0002886626150000054
Aryl sufoxy), substituted or unsubstituted alkenyl, substituted or unsubstituted silyl, substituted or unsubstituted boryl, substituted or unsubstituted amino, substituted or unsubstituted Aryl phosphino, substituted or unsubstituted phosphinoxide, substituted or unsubstituted Aryl, and substituted or unsubstituted heterocyclic group, or substituted with a substituent in which 2 or more substituents among the above-exemplified substituents are linked, or does not have any substituent. For example, "a substituent in which 2 or more substituents are linked" may be a biphenyl group. Namely, biphenyl groupIt may be an aryl group or a substituent in which 2 phenyl groups are bonded.
In the context of the present specification,
Figure GDA0002886626150000061
refers to a site that binds to other substituents or binding sites.
In the present specification, the halogen group may be fluorine, chlorine, bromine or iodine.
In the present specification, the number of carbon atoms in the imide group is not particularly limited, but is preferably 1 to 30. Specifically, the compound may have the following structure, but is not limited thereto.
Figure GDA0002886626150000062
In the present specification, with respect to the amide group, the nitrogen of the amide group may be substituted with hydrogen, a linear, branched or cyclic alkyl group having 1 to 30 carbon atoms, or an aryl group having 6 to 30 carbon atoms. Specifically, the compound may be a compound of the following structural formula, but is not limited thereto.
Figure GDA0002886626150000063
In the present specification, the number of carbon atoms of the carbonyl group is not particularly limited, but is preferably 1 to 30. Specifically, the compound may have the following structure, but is not limited thereto.
Figure GDA0002886626150000071
In the present specification, with respect to the ester group, the oxygen of the ester group may be substituted with a linear, branched or cyclic alkyl group having 1 to 25 carbon atoms or an aryl group having 6 to 30 carbon atoms. Specifically, the compound may be a compound of the following structural formula, but is not limited thereto.
Figure GDA0002886626150000072
In the present specification, the alkyl group may be linear or branched, and the number of carbon atoms is not particularly limited, but is preferably 1 to 30. Specific examples thereof include methyl group, ethyl group, propyl group, n-propyl group, isopropyl group, butyl group, n-butyl group, isobutyl group, tert-butyl group, sec-butyl group, 1-methylbutyl group, 1-ethylbutyl group, pentyl group, n-pentyl group, isopentyl group, neopentyl group, tert-pentyl group, hexyl group, n-hexyl group, 1-methylpentyl group, 2-methylpentyl group, 4-methyl-2-pentyl group, 3-dimethylbutyl group, 2-ethylbutyl group, heptyl group, n-heptyl group, 1-methylhexyl group, cyclopentylmethyl group, cyclohexylmethyl group, octyl group, n-octyl group, tert-octyl group, 1-methylheptyl group, 2-ethylhexyl group, 2-propylpentyl group, n-nonyl group, 2-dimethylheptyl group, 1-ethylpropyl group, 1-dimethylpropyl group, isohexyl group, 2-methylpentyl group, 4-methylhexyl, 5-methylhexyl, and the like, but are not limited thereto.
In the present specification, the cycloalkyl group is not particularly limited, but is preferably a cycloalkyl group having 3 to 30 carbon atoms, specifically, a cyclopropyl group, a cyclobutyl group, a cyclopentyl group, a 3-methylcyclopentyl group, a 2, 3-dimethylcyclopentyl group, a cyclohexyl group, a 3-methylcyclohexyl group, a 4-methylcyclohexyl group, a 2, 3-dimethylcyclohexyl group, a 3,4, 5-trimethylcyclohexyl group, a 4-tert-butylcyclohexyl group, a cycloheptyl group, a cyclooctyl group, and the like, but is not limited thereto.
In the present specification, the alkoxy group may be linear, branched or cyclic. The number of carbon atoms of the alkoxy group is not particularly limited, but the number of carbon atoms is preferably 1 to 30. Specifically, it may be methoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, tert-butoxy, sec-butoxy, n-pentoxy, neopentoxy, isopentoxy, n-hexoxy, 3-dimethylbutoxy, 2-ethylbutoxy, n-octoxy, n-nonoxy, n-decoxy, benzyloxy, p-methylbenzyloxy, etc., but is not limited thereto.
In the present specification, the amine group may be selected from-NH2Alkylamino, N-alkylarylamino, arylamino, N-arylheteroarylamino, N-alkylheteroarylamino and heteroarylamino groups having no particular number of carbon atomsBut are not limited to, but are preferably 1 to 30. Specific examples of the amine group include, but are not limited to, a methylamino group, a dimethylamino group, an ethylamino group, a diethylamino group, a phenylamino group, a naphthylamino group, a biphenylamino group, an anthrylamino group, a 9-methylanthrylamino group, a diphenylamino group, an N-phenylnaphthylamino group, a ditolylamino group, an N-phenyltolylamino group, a triphenylamino group, an N-phenylbiphenylamino group, an N-phenylnaphthylamino group, an N-biphenylnaphthylamino group, an N-naphthylfluorenylamino group, an N-phenylphenanthrylamino group, an N-biphenylphenanthrylamino group, an N-phenylfluorenylamino group, an N-phenylterphenylamino group, an N-phenanthrenylfluorenylamino group, and an N-biphenylfluorenylamino group.
In the present specification, the N-alkylarylamino group means an amino group in which an alkyl group and an aryl group are substituted on N of the amino group.
In the present specification, the N-arylheteroarylamino group means an amino group in which an aryl group and a heteroaryl group are substituted on the N of the amino group.
In the present specification, the N-alkylheteroarylamino group means an amino group in which an alkyl group and a heteroaryl group are substituted on N of the amino group.
In the present specification, alkylamino group, N-arylalkylamino group, alkylthio group: (
Figure GDA0002886626150000081
Figure GDA0002886626150000082
Alkyl thio xy), Alkyl sulfoxide group(s) ((II)
Figure GDA0002886626150000083
Alkyl groups in Alkyl sulfoxy) and N-alkylheteroarylamino groups are the same as those exemplified above for Alkyl groups. Specifically, examples of the alkylthio group include a methylthio group, an ethylthio group, a tert-butylthio group, a hexylthio group, and an octylthio group, and examples of the alkylsulfinyl group include a methylsulfonyl group
Figure GDA0002886626150000084
Ethyl sulfoxide group, propyl sulfoxide group, butyl sulfoxide group, etc., but are not limited thereto.
In the present specification, the alkenyl group may be linear or branched, and the number of carbon atoms is not particularly limited, but is preferably 2 to 30. Specific examples thereof include, but are not limited to, vinyl, 1-propenyl, isopropenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-pentenyl, 2-pentenyl, 3-methyl-1-butenyl, 1, 3-butadienyl, allyl, 1-phenylethen-1-yl, 2-diphenylethen-1-yl, 2-phenyl-2- (naphthalen-1-yl) ethen-1-yl, 2-bis (diphenylen-1-yl) ethen-1-yl, stilbenyl, and styryl.
In the present specification, specific examples of the silyl group include, but are not limited to, a trimethylsilyl group, a triethylsilyl group, a t-butyldimethylsilyl group, a vinyldimethylsilyl group, a propyldimethylsilyl group, a triphenylsilyl group, a diphenylsilyl group, and a phenylsilyl group.
In this specification, the boron group may be-BR100R101R is as defined above100And R101The same or different from each other, may be each independently selected from the group consisting of hydrogen, deuterium, a halogen group, a nitrile group, a substituted or unsubstituted monocyclic or polycyclic cycloalkyl group of carbon number 3 to 30, a substituted or unsubstituted linear or branched alkyl group of carbon number 1 to 30, a substituted or unsubstituted monocyclic or polycyclic aryl group of carbon number 6 to 30, and a substituted or unsubstituted monocyclic or polycyclic heteroaryl group of carbon number 2 to 30.
In the present specification, specific examples of the phosphine oxide group include a diphenylphosphine oxide group, a dinaphthylphosphine oxide group and the like, but the phosphine oxide group is not limited thereto.
In the present specification, the aryl group is not particularly limited, but is preferably an aryl group having 6 to 30 carbon atoms, and the aryl group may be monocyclic or polycyclic.
When the aryl group is a monocyclic aryl group, the number of carbon atoms is not particularly limited, but is preferably 6 to 30. Specifically, the monocyclic aryl group may be a phenyl group, a biphenyl group, a terphenyl group, or the like, but is not limited thereto.
When the aryl group is a polycyclic aryl group, the number of carbon atoms is not particularly limited, but is preferably 10 to 30. Specifically, asPolycyclic aromatic groups selected from naphthyl, anthryl, phenanthryl, triphenyl, pyrenyl, phenalenyl, perylenyl, perylene, and the like,
Figure GDA0002886626150000094
And a fluorenyl group, but the present invention is not limited thereto.
In the present specification, the above-mentioned fluorenyl group may be substituted, and adjacent groups may be bonded to each other to form a ring.
When the above-mentioned fluorenyl group is substituted, it may be
Figure GDA0002886626150000091
Figure GDA0002886626150000092
And
Figure GDA0002886626150000093
and the like. But is not limited thereto.
In the present specification, an "adjacent" group means a substituent substituted on an atom directly connected to an atom substituted with the substituent, a substituent closest to the substituent in terms of a steric structure, or another substituent substituted on an atom substituted with the substituent. For example, 2 substituents substituted at the ortho (ortho) position in the phenyl ring and 2 substituents substituted on the same carbon in the aliphatic ring may be interpreted as "adjacent" groups.
In the present specification, the aryl group in the aryloxy group, the arylthio group, the arylsulfoxide group, the N-arylalkylamino group, the N-arylheteroarylamino group, and the arylphosphine group is exemplified by the aryl group described above. Specifically, the aryloxy group includes, but is not limited to, phenoxy, p-tolyloxy, m-tolyloxy, 3, 5-dimethyl-phenoxy, 2,4, 6-trimethylphenoxy, p-tert-butylphenoxy, 3-biphenyloxy, 4-biphenyloxy, 1-naphthyloxy, 2-naphthyloxy, 4-methyl-1-naphthyloxy, 5-methyl-2-naphthyloxy, 1-anthracenyloxy, 2-anthracenyloxy, 9-anthracenyloxy, 1-phenanthrenyloxy, 3-phenanthrenyloxy, 9-phenanthrenyloxy, etc., and the arylthio group includes phenylthio, 2-methylphenylthio, 4-tert-butylphenylthio, etc., and the arylsulfoxido group includes phenylsulfoxido, p-methylsulfonimido, etc.
In the present specification, examples of the arylamine group include a substituted or unsubstituted monoarylamine group, a substituted or unsubstituted diarylamine group, or a substituted or unsubstituted triarylamine group. The aryl group in the arylamine group may be a monocyclic aryl group or a polycyclic aryl group. The arylamine group containing 2 or more aryl groups may contain a monocyclic aryl group, a polycyclic aryl group, or both a monocyclic aryl group and a polycyclic aryl group. For example, the aryl group in the arylamine group can be selected from the examples of the aryl group described above.
In the present specification, the heteroaryl group contains 1 or more heteroatoms other than carbon atoms, and specifically, the above-mentioned heteroatoms may contain 1 or more atoms selected from O, N, Se, S and the like. The number of carbon atoms is not particularly limited, but is preferably 2 to 30, and the heteroaryl group may be monocyclic or polycyclic. Examples of the heterocyclic group include thienyl, furyl, pyrrolyl, imidazolyl, thiazolyl, and the like,
Figure GDA0002886626150000101
Azolyl group,
Figure GDA0002886626150000102
Oxadiazolyl, pyridyl, bipyridyl, pyrimidinyl, triazinyl, triazolyl, acridinyl, pyridazinyl, pyrazinyl, quinolyl, quinazolinyl, quinoxalinyl, phthalazinyl, pyridopyrimidinyl, pyridopyrazinyl, pyrazinopyrazinyl, isoquinolyl, indolyl, carbazolyl, benzobenzoxazinyl
Figure GDA0002886626150000103
Azolyl, benzimidazolyl, benzothiazolyl, benzocarbazolyl, benzothienyl, dibenzothienyl, benzofuranyl, phenanthrolinyl, thiazolyl, isoquinoyl
Figure GDA0002886626150000104
Azolyl group,
Figure GDA0002886626150000105
Examples of the organic solvent include, but are not limited to, an organic solvent such as ethanol, and the like.
In the present specification, as examples of the heteroarylamino group, there are a substituted or unsubstituted monoheteroarylamino group, a substituted or unsubstituted diheteroarylamino group, or a substituted or unsubstituted triheteroarylamino group. The heteroarylamine group described above that contains more than 2 heteroaryl groups may contain a monocyclic heteroaryl group, a polycyclic heteroaryl group, or both a monocyclic heteroaryl group and a polycyclic heteroaryl group. For example, the heteroaryl group in the heteroarylamino group can be selected from the examples of the heteroaryl group described above.
In this specification, examples of the heteroaryl group in the N-arylheteroarylamino group and the N-alkylheteroarylamino group are the same as those of the heteroaryl group described above.
In the present specification, arylene means an aryl group having two binding sites on the aryl group, i.e., a 2-valent group. The above description of aryl groups applies in addition to the 2-valent groups.
In the present specification, heteroarylene means an aryl group having two binding sites on the heteroaryl group, i.e., a 2-valent group. The above description of heteroaryl groups can be applied, except that they are each a 2-valent group.
In the present specification, a substituted or unsubstituted ring formed by bonding adjacent groups to each other, and a "ring" refers to a substituted or unsubstituted hydrocarbon ring or a substituted or unsubstituted heterocyclic ring.
In the present specification, the hydrocarbon ring may be aromatic, aliphatic, or a fused ring of aromatic and aliphatic, and may be selected from the cycloalkyl groups and the aryl groups described above, except that the above is not 1-valent.
In the present specification, the aromatic ring may be a monocyclic ring or a polycyclic ring, and may be selected from the above-mentioned examples of aryl groups except for having a valence of 1.
In the present specification, the heterocyclic ring contains 1 or more hetero atoms other than carbon atoms, and specifically, the hetero atom may contain 1 or more atoms selected from O, N, Se, S, and the like. The heterocyclic ring may be monocyclic or polycyclic, may be aromatic, aliphatic, or a condensed ring of aromatic and aliphatic, and may be selected from the examples of the heteroaryl group and the heterocyclic group except that it has a valence of 1.
According to an embodiment of the present specification, the chemical formula 1 may be represented by any one of the following chemical formulas 1-1 to 1-4.
[ chemical formula 1-1]
Figure GDA0002886626150000111
[ chemical formulas 1-2]
Figure GDA0002886626150000121
[ chemical formulas 1-3]
Figure GDA0002886626150000122
[ chemical formulas 1 to 4]
Figure GDA0002886626150000131
In the above chemical formulas 1-1 to 1-4,
x1, L1, n, Y1 to Y4, R1, R2 and R4 to R12 are as defined above in chemical formula 1,
ar1 and R15 to R18 are as defined above for formula 2.
According to an embodiment of the present disclosure, in chemical formula 1, Y1 and Y3 are N, Y2 is CR13, and Y4 is CR 14.
According to an embodiment of the present disclosure, in chemical formula 1, Y2 and Y4 are N, Y1 is CR14, and Y3 is CR 13.
According to an embodiment of the present disclosure, R13 is a group bonded to L1.
According to an embodiment of the present specification, the chemical formula 1 is represented by any one of the following chemical formulas 1-5 to 1-12.
[ chemical formulas 1 to 5]
Figure GDA0002886626150000141
[ chemical formulas 1 to 6]
Figure GDA0002886626150000142
[ chemical formulas 1 to 7]
Figure GDA0002886626150000151
[ chemical formulas 1 to 8]
Figure GDA0002886626150000152
[ chemical formulas 1 to 9]
Figure GDA0002886626150000161
[ chemical formulas 1-10]
Figure GDA0002886626150000162
[ chemical formula-11 ]
Figure GDA0002886626150000171
[ chemical formulas 1 to 12]
Figure GDA0002886626150000172
In the above chemical formulas 1-5 to 1-12,
x1, L1, n, R1, R2, R4 to R12 and R14 are as defined above,
ar1 and R15 to R18 are as defined above for formula 2.
According to an embodiment of the present specification, the chemical formula 1 is represented by any one of the following chemical formulas 1-13 to 1-20.
[ chemical formulas 1 to 13]
Figure GDA0002886626150000181
[ chemical formulas 1 to 14]
Figure GDA0002886626150000182
[ chemical formulas 1 to 15]
Figure GDA0002886626150000191
[ chemical formulas 1 to 16]
Figure GDA0002886626150000192
[ chemical formulas 1 to 17]
Figure GDA0002886626150000201
[ chemical formulas 1 to 18]
Figure GDA0002886626150000202
[ chemical formulas 1 to 19]
Figure GDA0002886626150000211
[ chemical formulas 1 to 20]
Figure GDA0002886626150000212
In the above chemical formulas 1-13 to 1-20,
l1, n, R1, R2, R4 to R12 and R14 are as defined above,
ar1 and R15 to R18 are as defined above for formula 2.
According to an embodiment of the present specification, the above chemical formula 1 is represented by any one of the following chemical formulas 1-21 to 1-28.
[ chemical formulas 1 to 21]
Figure GDA0002886626150000221
[ chemical formulas 1 to 22]
Figure GDA0002886626150000222
[ chemical formulas 1 to 23]
Figure GDA0002886626150000231
[ chemical formulas 1 to 24]
Figure GDA0002886626150000232
[ chemical formulas 1 to 25]
Figure GDA0002886626150000241
[ chemical formulas 1 to 26]
Figure GDA0002886626150000242
[ chemical formulas 1 to 27]
Figure GDA0002886626150000251
[ chemical formulas 1 to 28]
Figure GDA0002886626150000252
In the above chemical formulas 1-21 to 1-28,
l1, n, R1, R2, R4 to R12 and R14 are as defined above,
ar1 and R15 to R18 are as defined above for formula 2.
According to an embodiment of the present disclosure, R14 is a substituted or unsubstituted aryl group.
According to an embodiment of the present disclosure, R14 is an aryl group.
According to an embodiment of the present disclosure, R14 is phenyl or naphthyl.
According to an embodiment of the present specification, Ar1 represents an aryl group or a heteroaryl group substituted or unsubstituted with an aryl group.
According to one embodiment of the present specification, Ar1 is a phenyl group, a biphenyl group, a naphthyl group, a phenanthryl group, a fluoranthenyl group, a triphenylene group, a pyrenyl group, a pyridyl group, a pyrimidyl group, a triazinyl group substituted with an aryl group, or a quinazolinyl group substituted or unsubstituted with an aryl group.
According to one embodiment of the present specification, Ar1 is a phenyl group, a biphenyl group, a naphthyl group, a phenanthryl group, a fluoranthenyl group, a triphenylene group, a pyrenyl group, a pyridyl group, a pyrimidyl group, a triazinyl group substituted with a phenyl group, or a quinazolinyl group substituted or unsubstituted with a phenyl group or a naphthyl group.
According to an embodiment of the present disclosure, the chemical formula 1 may be selected from the following compounds.
Figure GDA0002886626150000271
Figure GDA0002886626150000281
Figure GDA0002886626150000291
Figure GDA0002886626150000301
Figure GDA0002886626150000311
Figure GDA0002886626150000321
Figure GDA0002886626150000331
Figure GDA0002886626150000341
Figure GDA0002886626150000351
Figure GDA0002886626150000361
Figure GDA0002886626150000371
Figure GDA0002886626150000381
Figure GDA0002886626150000391
Figure GDA0002886626150000401
Figure GDA0002886626150000411
Figure GDA0002886626150000421
Figure GDA0002886626150000431
Figure GDA0002886626150000441
Figure GDA0002886626150000451
Figure GDA0002886626150000461
Figure GDA0002886626150000471
Figure GDA0002886626150000481
Figure GDA0002886626150000491
Figure GDA0002886626150000501
Figure GDA0002886626150000511
Figure GDA0002886626150000521
Figure GDA0002886626150000531
Figure GDA0002886626150000541
Figure GDA0002886626150000551
Figure GDA0002886626150000561
Figure GDA0002886626150000571
Figure GDA0002886626150000581
Figure GDA0002886626150000591
Figure GDA0002886626150000601
Figure GDA0002886626150000611
Figure GDA0002886626150000621
Figure GDA0002886626150000631
Figure GDA0002886626150000641
Figure GDA0002886626150000651
Figure GDA0002886626150000661
Figure GDA0002886626150000671
Figure GDA0002886626150000681
Figure GDA0002886626150000691
Figure GDA0002886626150000701
Figure GDA0002886626150000711
Figure GDA0002886626150000721
Figure GDA0002886626150000731
Figure GDA0002886626150000741
Figure GDA0002886626150000751
Figure GDA0002886626150000761
Figure GDA0002886626150000771
Figure GDA0002886626150000781
Figure GDA0002886626150000791
Figure GDA0002886626150000801
Figure GDA0002886626150000811
According to one embodiment of the present specification, there is provided an organic light-emitting element including: the organic light-emitting device includes a first electrode, a second electrode provided so as to face the first electrode, and 1 or more organic layers provided between the first electrode and the second electrode, wherein one or more of the organic layers include the heterocyclic compound.
According to one embodiment of the present description, the organic layer of the organic light-emitting device of the present description may be formed of a single layer structure, or may be formed of a multilayer structure in which 2 or more organic layers are stacked. For example, the organic light-emitting element of the present invention may have a structure including a hole injection layer, a hole transport layer, an electron blocking layer, a light-emitting layer, a hole blocking layer, an electron transport layer, an electron injection layer, and the like as an organic layer. However, the structure of the organic light emitting element is not limited thereto, and fewer or more organic layers may be included.
For example, the structure of the organic light-emitting element in the present specification may have the structure shown in fig. 1 and 2, but is not limited thereto.
Fig. 1 illustrates a structure of an organic light emitting element 10 in which a first electrode 30, a light emitting layer 40, and a second electrode 50 are sequentially stacked on a substrate 20. Fig. 1 illustrates an exemplary structure of an organic light emitting device according to an embodiment of the present disclosure, and may further include another organic layer.
Fig. 2 illustrates a structure of an organic light emitting element in which a first electrode 30, a hole injection layer 60, a hole transport layer 70, a light emitting layer 40, an electron transport layer 80, an electron injection layer 90, and a second electrode 50 are sequentially stacked on a substrate 20. Fig. 2 shows an exemplary structure of the embodiment of the present specification, and may further include another organic layer.
According to one embodiment of the present disclosure, the organic layer includes a hole transport layer, and the hole transport layer includes a heterocyclic compound represented by the chemical formula 1.
According to one embodiment of the present disclosure, the organic layer includes an electron transport layer, an electron injection layer, or a layer that transports and injects electrons at the same time, and the electron transport layer, the electron injection layer, or the layer that transports and injects electrons at the same time includes the heterocyclic compound.
According to one embodiment of the present disclosure, the organic layer includes a light emitting layer, and the light emitting layer includes a heterocyclic compound represented by the chemical formula 1.
According to one embodiment of the present disclosure, the organic layer includes a light emitting layer, and the light emitting layer includes a heterocyclic compound represented by the chemical formula 1 as a host material of the light emitting layer.
In one embodiment of the present specification, the organic layer includes a heterocyclic compound represented by the chemical formula 1 as a host material, and may include other organic compounds, metals, or metal compounds as a dopant.
The dopant may be 1 or more selected from the following exemplified compounds, but is not limited thereto.
Figure GDA0002886626150000831
Figure GDA0002886626150000841
According to an embodiment of the present disclosure, the organic layer may further include 1 or more layers selected from a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, and an electron injection layer.
In the organic light-emitting element of the present specification, 1 or more of the organic layers may be produced using a material and a method known in the art, except that the heterocyclic compound of the present specification, that is, the heterocyclic compound represented by the above chemical formula 1 is included.
When the organic light emitting element includes a plurality of organic layers, the organic layers may be formed of the same substance or different substances.
For example, the organic light-emitting element in this specification can be manufactured by stacking a first electrode, an organic layer, and a second electrode in this order on a substrate. In this case, the following method can be used: a first electrode is formed by depositing metal, a metal oxide having conductivity, or an alloy thereof on a substrate by a Physical Vapor Deposition (PVD) method such as a sputtering method or an electron beam evaporation (e-beam evaporation) method, an organic layer including a hole injection layer, a hole transport layer, a light emitting layer, and an electron transport layer is formed on the first electrode, and a substance which can be used as a second electrode is deposited on the organic layer. In addition to the above method, the second electrode material, the organic layer, and the first electrode material may be sequentially deposited on the substrate to manufacture the organic light-emitting element. In addition, regarding the heterocyclic compound represented by the above chemical formula 1, in the manufacture of the organic light emitting element, the organic layer may be formed not only by a vacuum evaporation method but also by a solution coating method. Here, the solution coating method refers to spin coating, dip coating, blade coating, inkjet printing, screen printing, spraying, roll coating, and the like, but is not limited thereto.
According to an embodiment of the present disclosure, the first electrode is an anode, and the second electrode is a cathode.
In another embodiment of the present disclosure, the first electrode is a cathode, and the second electrode is an anode.
The anode material is preferably a material having a large work function in order to smoothly inject holes into the organic layer. As specific examples of the anode material which can be used in the present invention, metals such as vanadium, chromium, copper, zinc, gold, or alloys thereof; metal oxides such as zinc oxide, Indium Tin Oxide (ITO), Indium Zinc Oxide (IZO), and the like; such as ZnO, Al or SnO2A combination of a metal such as Sb and an oxide; such as poly (3-methylthiophene), poly [3,4- (ethylene-1, 2-dioxy) thiophene]Conductive polymers such as (PEDOT), polypyrrole, and polyaniline, but the present invention is not limited thereto.
The cathode material is preferably a material having a small work function in order to easily inject electrons into the organic layer. As specific examples of the cathode material, there are magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin andmetals such as lead or alloys thereof; such as LiF/Al or LiO2Multilayer structure materials such as/Al, Mg/Ag, etc., but not limited thereto.
The hole injection layer is a layer for injecting holes from the electrode, and the following compounds are preferable as the hole injection substance: has an ability to transport holes, has a hole injection effect from the anode, has an excellent hole injection effect with respect to the light-emitting layer or the light-emitting material, prevents excitons generated in the light-emitting layer from migrating to the electron injection layer or the electron injection material, and has excellent thin film-forming ability. Preferably, the HOMO (highest occupied molecular orbital) of the hole injecting species is between the work function of the anode species and the HOMO of the surrounding organic layer. Specific examples of the hole injecting substance include, but are not limited to, metalloporphyrin (porphyrin), oligothiophene, arylamine-based organic substances, hexanitrile-hexaazatriphenylene-based organic substances, quinacridone-based organic substances, perylene-based organic substances, anthraquinone, polyaniline, and polythiophene-based conductive polymers.
The hole transport layer is a layer that receives holes from the hole injection layer and transports the holes to the light-emitting layer, and the hole transport material is a material that can receive holes from the anode or the hole injection layer and transport the holes to the light-emitting layer. Specific examples thereof include, but are not limited to, arylamine-based organic materials, conductive polymers, and block copolymers in which a conjugated portion and a non-conjugated portion are present simultaneously.
The electron blocking layer is a layer which prevents electrons injected from the electron injection layer from entering the hole injection layer through the light-emitting layer, and can improve the life and efficiency of the element.
The light-emitting substance of the light-emitting layer is a substance that can receive holes and electrons from the hole-transporting layer and the electron-transporting layer, respectively, and combine them to emit light in the visible light region, and a substance having a high quantum efficiency with respect to fluorescence or phosphorescence is preferable. As an example, there is an 8-hydroxyquinoline aluminum complex (Alq)3) (ii) a A carbazole-based compound; dimeric styryl (dimerized styryl) compounds; BAlq; 10-hydroxybenzoquinoline metal compounds; benzo (b) is
Figure GDA0002886626150000862
Azole, benzothiazole and benzimidazole-based compounds; poly (p-phenylene vinylene) (PPV) polymers; spiro (spiroo) compounds; polyfluorene, rubrene, and the like, but are not limited thereto.
The light emitting layer may include a host material and a dopant material. The host material includes aromatic fused ring derivatives, heterocyclic compounds, and the like. Specifically, the aromatic condensed ring derivatives include anthracene derivatives, pyrene derivatives, naphthalene derivatives, pentacene derivatives, phenanthrene compounds, fluoranthene compounds, and the like, and the heterocyclic ring-containing compounds include carbazole derivatives, dibenzofuran derivatives, and ladder-type furan compounds
Figure GDA0002886626150000861
Pyrimidine derivatives, etc., but are not limited thereto.
As the dopant material, there are aromatic amine derivatives, styryl amine compounds, boron complexes, fluoranthene compounds, metal complexes, and the like. Specifically, the aromatic amine derivative is an aromatic fused ring derivative having a substituted or unsubstituted arylamine group, and includes pyrene, anthracene, or the like having an arylamine group,
Figure GDA0002886626150000863
Diindenoperene (Periflanthene) and the like, as the styrene amine compound, a compound in which at least 1 arylvinyl group is substituted on a substituted or unsubstituted arylamine, and which is substituted or unsubstituted with 1 or 2 or more substituents selected from the group consisting of an aryl group, a silyl group, an alkyl group, a cycloalkyl group and an arylamino group. Specific examples thereof include, but are not limited to, styrylamine, styryldiamine, styryltrimethylamine, and styryltretramine. The metal complex includes, but is not limited to, iridium complexes and platinum complexes.
The hole-blocking layer is a layer that prevents holes injected from the hole-injecting layer from entering the electron-injecting layer through the light-emitting layer, and can improve the life and efficiency of the element.
The electron transport layer is a layer that receives electrons from the electron injection layer and transports the electrons to the light-emitting layer, and the electron transport layer is a substance that can favorably receive electrons from the cathode and transfer the electrons to the light-emitting layer, and a substance having a large electron mobility is suitable. Specific examples thereof include Al complexes of 8-hydroxyquinoline and Al complexes containing Alq3The complex of (3), the organic radical compound, the hydroxyflavone-metal complex, etc., but are not limited thereto. The electron transport layer may be used with any desired cathode material as used in the art. In particular, examples of suitable cathode substances are the usual substances having a low work function and associated with an aluminum or silver layer. Specifically, cesium, barium, calcium, ytterbium and samarium are present, for each, along with an aluminum or silver layer.
The electron injection layer is a layer for injecting electrons from the electrode, and is preferably a compound of: has an ability to transport electrons, an electron injection effect from a cathode, an excellent electron injection effect for a light-emitting layer or a light-emitting material, prevents excitons generated in the light-emitting layer from migrating to a hole-injecting layer, and is excellent in thin film-forming ability. Specifically, there are fluorenone, anthraquinone dimethane (Anthraquinodimethane), diphenoquinone, thiopyran dioxide, and,
Figure GDA0002886626150000871
Oxazole, two
Figure GDA0002886626150000872
Examples of the nitrogen-containing five-membered ring include, but are not limited to, oxazoles, triazoles, imidazoles, perylene tetracarboxylic acids, fluorenylidene methanes, anthrones, and derivatives thereof, metal complexes, and nitrogen-containing five-membered ring derivatives.
Examples of the metal complexes include lithium 8-quinolinolato, zinc bis (8-quinolinolato), copper bis (8-quinolinolato), manganese bis (8-quinolinolato), aluminum tris (2-methyl-8-quinolinolato), gallium tris (8-quinolinolato), bis (10-hydroxybenzo [ h ] quinoline) beryllium, bis (10-hydroxybenzo [ h ] quinoline) zinc, bis (2-methyl-8-quinoline) gallium chloride, bis (2-methyl-8-quinoline) (o-cresol) gallium, bis (2-methyl-8-quinoline) (1-naphthol) aluminum, bis (2-methyl-8-quinoline) (2-naphthol) gallium, and the like, but are not limited thereto.
The organic light emitting element of the present specification may be a top emission type, a bottom emission type, or a bidirectional emission type depending on a material used.
According to an embodiment of the present specification, the heterocyclic compound represented by the above chemical formula 1 may be included in an organic solar cell or an organic transistor in addition to the organic light emitting element.
Examples
Hereinafter, the present specification will be described in detail with reference to examples. However, the embodiments according to the present description may be modified into various other forms, and the scope of the present description should not be construed as being limited to the embodiments described in detail below. The embodiments of the present description are provided to more fully describe the present description to those skilled in the art.
The heterocyclic compound according to one embodiment of the present specification can be produced by the basic synthesis process (scheme) of the following reaction formulae 1 to 8, but is not limited thereto.
[ reaction formula 1]
Figure GDA0002886626150000881
[ reaction formula 2]
Figure GDA0002886626150000882
[ reaction formula 3]
Figure GDA0002886626150000891
[ reaction formula 4]
Figure GDA0002886626150000892
[ reaction formula 5]
Figure GDA0002886626150000901
[ reaction formula 6]
Figure GDA0002886626150000902
[ reaction formula 7]
Figure GDA0002886626150000911
[ reaction formula 8]
Figure GDA0002886626150000912
In the above reaction formulae 1 to 8, X1, R14, L1 and n are defined as in the above chemical formula 1, and Ar1 is defined as in the above chemical formula 2.
According to one embodiment of the present specification, the intermediates a-1 and a-2 can be produced by the following reaction formulae 9 and 10, but are not limited thereto.
[ reaction formula 9]
Figure GDA0002886626150000921
[ reaction formula 10]
Figure GDA0002886626150000922
In the above reaction formulae 9 and 10, X1 and R14 are defined as in the above chemical formula 1.
PREPARATION EXAMPLE 1 Synthesis of Compound A-1-1
Figure GDA0002886626150000923
In a round-bottom flask, 2, 4-dichlorobenzo [4,5]]Thieno [3,4-d]Pyrimidine (10g,0.04mol), phenylboronic acid (4.8g,0.04mol), calcium carbonate (8.3g,0.06mol), and Pd (PPh)3)4(1.8g,4 mol%) was dissolved in anhydrous tetrahydrofuran and water, and the mixture was refluxed at 80 ℃ for 4 hours. After the reaction, the temperature of the reaction product was cooled to room temperature, and the reaction product was extracted with chloroform. The extracted organic layer was dehydrated over anhydrous magnesium sulfate and recrystallized from Ethyl acetate (Ethyl acetate) to obtain compound a-1-1(9.53g, 82%).
PREPARATION EXAMPLE 2 Synthesis of Compound A-1-2
Figure GDA0002886626150000931
Compound A-1-2 was obtained in the same manner as in production example 1 except that 1-naphthylboronic acid was used instead of phenylboronic acid.
PREPARATION EXAMPLE 3 Synthesis of Compound A-1-3
Figure GDA0002886626150000932
Compound A-1-3 was obtained in the same manner as in production example 1 except that 2-naphthylboronic acid was used instead of phenylboronic acid.
PREPARATION EXAMPLE 4 Synthesis of Compound A-1-4
Figure GDA0002886626150000933
Compound A-1-4 was obtained in the same manner as in production example 1 except that [1,1' -biphenyl ] -4-ylboronic acid was used in place of phenylboronic acid.
PREPARATION EXAMPLE 5 Synthesis of Compound A-2-1
Figure GDA0002886626150000941
Compound A-2-1 was obtained in the same manner as in preparation example 1 except that 2, 4-dichlorobenzofuran [3,2-d ] pyrimidine was used in place of 2, 4-dichlorobenzo [4,5] thieno [3,4-d ] pyrimidine.
PREPARATION EXAMPLE 6 Synthesis of Compound A-2-2
Figure GDA0002886626150000942
Compound A-2-2 was obtained in the same manner as in preparation example 1 except that 2, 4-dichlorobenzofuran [3,2-d ] pyrimidine was used in place of 2, 4-dichlorobenzo [4,5] thieno [3,4-d ] pyrimidine and 1-naphthylboronic acid was used in place of phenylboronic acid.
PREPARATION EXAMPLE 7 Synthesis of Compound A-2-3
Figure GDA0002886626150000943
Compound A-2-3 was obtained in the same manner as in preparation example 1 except that 2, 4-dichlorobenzofuran [3,2-d ] pyrimidine was used in place of 2, 4-dichlorobenzo [4,5] thieno [3,4-d ] pyrimidine and 2-naphthylboronic acid was used in place of phenylboronic acid.
PREPARATION EXAMPLE 8 Synthesis of Compound A-2-4
Figure GDA0002886626150000951
Compound A-2-4 was obtained in the same manner as in preparation example 1 except that 2, 4-dichlorobenzofuran [3,2-d ] pyrimidine was used in place of 2, 4-dichlorobenzo [4,5] thieno [3,4-d ] pyrimidine and [1,1' -biphenyl ] -4-ylboronic acid was used in place of phenylboronic acid.
PREPARATION EXAMPLE 9 Synthesis of Compound A-3-1
Figure GDA0002886626150000952
Compound A-3-1 was obtained in the same manner as in production example 1 except that 2, 4-dichlorobenzo [4,5] thieno [2,3-d ] pyrimidine was used in place of 2, 4-dichlorobenzo [4,5] thieno [3,4-d ] pyrimidine.
PREPARATION EXAMPLE 10 Synthesis of Compound A-3-2
Figure GDA0002886626150000953
Compound A-3-2 was obtained in the same manner as in production example 1 except that 2, 4-dichlorobenzo [4,5] thieno [2,3-d ] pyrimidine was used in place of 2, 4-dichlorobenzo [4,5] thieno [3,4-d ] pyrimidine and 1-naphthylboronic acid was used in place of phenylboronic acid.
PREPARATION EXAMPLE 11 Synthesis of Compound A-3-3
Figure GDA0002886626150000961
Compound A-3-3 is obtained in the same manner as in production example 1 except that 2, 4-dichlorobenzo [4,5] thieno [2,3-d ] pyrimidine is used in place of 2, 4-dichlorobenzo [4,5] thieno [3,4-d ] pyrimidine and 2-naphthylboronic acid is used in place of phenylboronic acid.
PREPARATION EXAMPLE 12 Synthesis of Compound A-3-4
Figure GDA0002886626150000962
Compound A-3-4 can be obtained in the same manner as in production example 1 except that 2, 4-dichlorobenzo [4,5] thieno [2,3-d ] pyrimidine is used in place of 2, 4-dichlorobenzo [4,5] thieno [3,4-d ] pyrimidine and [1,1' -biphenyl ] -4-ylboronic acid is used in place of phenylboronic acid.
PREPARATION EXAMPLE 13 Synthesis of Compound A-4-1
Figure GDA0002886626150000963
Compound A-4-1 was obtained in the same manner as in preparation example 1 except that 2, 4-dichlorobenzofuran [2,3-d ] pyrimidine was used in place of 2, 4-dichlorobenzo [4,5] thieno [3,4-d ] pyrimidine.
PREPARATION EXAMPLE 14 Synthesis of Compound A-4-2
Figure GDA0002886626150000971
Compound A-4-2 was obtained in the same manner as in preparation example 1 except that 2, 4-dichlorobenzofuran [2,3-d ] pyrimidine was used in place of 2, 4-dichlorobenzo [4,5] thieno [3,4-d ] pyrimidine and 1-naphthylboronic acid was used in place of phenylboronic acid.
PREPARATION EXAMPLE 15 Synthesis of Compound A-4-3
Figure GDA0002886626150000972
Compound A-4-3 is obtained in the same manner as in production example 1 except that 2, 4-dichlorobenzofuran [2,3-d ] pyrimidine is used instead of 2, 4-dichlorobenzo [4,5] thieno [3,4-d ] pyrimidine, and 2-naphthylboronic acid is used instead of phenylboronic acid.
PREPARATION EXAMPLE 16 Synthesis of Compound A-4-4
Figure GDA0002886626150000973
Compound A-4-4 was obtained in the same manner as in preparation example 1 except that 2, 4-dichlorobenzofuran [2,3-d ] pyrimidine was used in place of 2, 4-dichlorobenzo [4,5] thieno [3,4-d ] pyrimidine and [1,1' -biphenyl ] -4-ylboronic acid was used in place of phenylboronic acid.
Preparation example 17 Synthesis of Compound B- (a) -1
Figure GDA0002886626150000981
In a round-bottomed flask, compound A-1-1(10g,0.034mol), 5, 6-indolino [2,3-b ] carbazole (8.6g,0.034mol), potassium phosphate (14.3g,0.067mol) were dissolved in 100ml of N, N-Dimethylacetamide (N, N-Dimethylacetamide), and the mixture was refluxed at 160 ℃ for 1 hour. After the reaction is finished, cooling the temperature to normal temperature, pouring the reactant into water to separate out solid, and filtering. The filtered solid was dissolved in chloroform and extracted. The extracted organic layer was dehydrated over anhydrous magnesium sulfate and recrystallized from Ethyl acetate (Ethyl acetate) to obtain compound B- (a) -1(14.8g, 85%).
Preparation example 18 Synthesis of Compound B- (a) -2
Figure GDA0002886626150000982
Compound B- (a) -2 was obtained in the same manner as in preparation example 17, except that Compound A-2-2 was used in place of Compound A-1-1.
Preparation example 19 Synthesis of Compound B- (B) -1
Figure GDA0002886626150000991
Compound B- (B) -1 was obtained in the same manner as in production example 17, except that 5, 11-indolino [3,2-B ] carbazole was used instead of 5, 6-indolino [2,3-B ] carbazole and compound a-3-2 was used instead of compound a-1-1.
Preparation example 20 Synthesis of Compound B- (B) -2
Figure GDA0002886626150000992
Compound B- (B) -2 was obtained in the same manner as in preparation example 17, except that 5, 11-indolino [3,2-B ] carbazole was used instead of 5, 6-indolino [2,3-B ] carbazole and compound a-4-3 was used instead of compound a-1-1.
Preparation example 21 Synthesis of Compound B- (c) -1
Figure GDA0002886626150001001
Compound B- (c) -1 was obtained in the same manner as in production example 17, except that 5, 8-indolino [2,3-c ] carbazole was used instead of 5, 6-indolino [2,3-B ] carbazole and compound a-2-2 was used instead of compound a-1-1.
Preparation example 22 Synthesis of Compound B- (c) -2
Figure GDA0002886626150001002
Compound B- (c) -2 was obtained in the same manner as in production example 17, except that 5, 8-indolino [2,3-c ] carbazole was used instead of 5, 6-indolino [2,3-B ] carbazole and compound a-3-1 was used instead of compound a-1-1.
Preparation example 23 Synthesis of Compound B- (d) -1
Figure GDA0002886626150001011
Compound B- (d) -1 was obtained in the same manner as in production example 17, except that 5, 12-indolino [3,2-a ] carbazole was used instead of 5, 6-indolino [2,3-B ] carbazole and compound a-1-3 was used instead of compound a-1-1.
Preparation example 24 Synthesis of Compound B- (d) -2
Figure GDA0002886626150001012
Compound B- (d) -2 was obtained in the same manner as in production example 17, except that 5, 12-indolino [3,2-a ] carbazole was used instead of 5, 6-indolino [2,3-B ] carbazole and compound a-4-1 was used instead of compound a-1-1.
Synthesis example 1 Synthesis of Compound 1
Figure GDA0002886626150001013
A round-bottomed flask was charged with compound B- (a) -1(10g,0.019mol), 1-bromonaphthalene (4g,0.019mol) and potassium phosphate (8.2g,0.038mol), and bis (tri-tert-butylphosphine) palladium (0.02g,0.2 mol%) was added under reflux for further 4 hours under reflux. After the reaction was completed, the temperature was cooled to normal temperature, and the precipitated solid was filtered. Then, the filtered solid was dissolved in chloroform and extracted. The extracted organic layer was dehydrated over anhydrous magnesium sulfate and recrystallized from Ethyl acetate (Ethyl acetate) to obtain 9.7g (78%) of compound 1 (example 1-2). ([ M + H ] ═ 643)
Fig. 3 is a mass spectrum of compound 1 produced in synthesis example 1.
Synthesis example 2 Synthesis of Compound 2
Figure GDA0002886626150001021
Compound 2 (examples 1 to 12) was obtained in the same manner as in Synthesis example 1 except that 2-chloropyrimidine was used in place of 1-bromonaphthalene. ([ M + H ] ═ 595)
Fig. 4 is a mass spectrum of compound 2 produced in synthesis example 2.
Synthesis example 3 Synthesis of Compound 3
Figure GDA0002886626150001022
Compound 3 (examples 1 to 17) was obtained in the same manner as in Synthesis example 1 except that 2-chloro-4, 6-diphenyl-1, 3, 5-triazine was used in place of 1-bromonaphthalene. ([ M + H ] ═ 748)
Fig. 5 is a mass spectrum of compound 3 produced in synthesis example 3.
Synthesis example 4 Synthesis of Compound 4
Figure GDA0002886626150001031
Compound 4 (examples 1 to 120) was obtained in the same manner as in Synthesis example 1, except that 1-bromobenzene was used in place of 1-bromonaphthalene and that compound B- (a) -2 was used in place of compound B- (a) -1. ([ M + H ] ═ 628)
Fig. 6 is a mass spectrum of compound 4 produced in synthesis example 4.
Synthesis example 5 Synthesis of Compound 5
Figure GDA0002886626150001032
Compound 5 (examples 1 to 124) was obtained in the same manner as in Synthesis example 1, except that 9-bromophenanthrene was used in place of 1-bromonaphthalene and that compound B- (a) -2 was used in place of compound B- (a) -1. ([ M + H ] ═ 727)
Fig. 7 is a mass spectrum of compound 5 produced in synthesis example 5.
Synthesis example 6 Synthesis of Compound 6
Figure GDA0002886626150001041
Compound 6 (examples 1 to 134) was obtained in the same manner as in Synthesis example 1, except that 2-chloro-4-phenylquinazoline was used in place of 1-bromonaphthalene and that compound B- (a) -2 was used in place of compound B- (a) -1. ([ M + H ] ═ 755)
Fig. 8 is a mass spectrum of compound 6 produced in synthesis example 6.
Synthesis example 7 Synthesis of Compound 7
Figure GDA0002886626150001042
Compound 7 (specific examples 2 to 74) ([ M + H ] ═ 768) was obtained in the same manner as in synthesis example 1, except that 3-chlorofluoranthene was used instead of 1-bromonaphthalene and compound B- (B) -1 was used instead of compound B- (a) -1
Fig. 9 is a mass spectrum of compound 7 produced in synthesis example 7.
Synthesis example 8 Synthesis of Compound 8
Figure GDA0002886626150001051
Compound 8 (examples 2 to 76) was obtained in the same manner as in Synthesis example 1, except that 1-bromopyrene was used in place of 1-bromonaphthalene and that compound B- (B) -1 was used in place of compound B- (a) -1. ([ M + H ] ═ 768)
Fig. 10 is a mass spectrum of compound 8 produced in synthesis example 8.
Synthesis example 9 Synthesis of Compound 9
Figure GDA0002886626150001052
Compound 9 (examples 2 to 84) was obtained in the same manner as in Synthesis example 1 except that 2-chloro-4- (naphthalen-2-yl) quinazoline was used in place of 1-bromonaphthalene and that compound B- (B) -1 was used in place of compound B- (a) -1. ([ M + H ] ═ 822)
Fig. 11 is a mass spectrum of compound 9 produced in synthesis example 9.
Synthesis example 10 Synthesis of Compound 10
Figure GDA0002886626150001061
Compound 10 (example 2-188) was obtained in the same manner as in 3-1) except that 1-bromobenzene was used instead of 1-bromonaphthalene and compound B- (B) -2 was used instead of compound B- (a) -1 in synthetic example 1. ([ M + H ] ═ 628)
Fig. 12 is a mass spectrum of compound 10 produced in synthesis example 10.
Synthesis example 11 Synthesis of Compound 11
Figure GDA0002886626150001062
Compound 11 (examples 2 to 194) was obtained in the same manner as in Synthesis example 1, except that 2-bromotriphenylene was used in place of 1-bromonaphthalene and that compound B- (B) -2 was used in place of compound B- (a) -1. ([ M + H ] ═ 778)
Fig. 13 is a mass spectrum of compound 11 produced in synthesis example 11.
Synthesis example 12 Synthesis of Compound 12
Figure GDA0002886626150001071
Compound 12 (specific examples 2 to 200) was obtained in the same manner as in Synthesis example 1 except that 4-chloropyrimidine was used in place of 1-bromonaphthalene and that compound B- (B) -2 was used in place of compound B- (a) -1. ([ M + H ] ═ 629)
Fig. 14 is a mass spectrum of compound 12 produced in synthesis example 12.
Synthesis example 13 Synthesis of Compound 13
Figure GDA0002886626150001072
Compound 13 (examples 3 to 122) was obtained in the same manner as in Synthesis example 1, except that 2-bromonaphthalene was used in place of 1-bromonaphthalene and that compound B- (c) -1 was used in place of compound B- (a) -1. ([ M + H ] ═ 678)
Fig. 15 is a mass spectrum of compound 13 produced in synthesis example 13.
Synthesis example 14 Synthesis of Compound 14
Figure GDA0002886626150001081
Compound 14 (specific examples 3 to 129) was obtained in the same manner as in Synthesis example 1 except that 3-chloropyridine was used in place of 1-bromonaphthalene and Compound B- (c) -1 was used in place of Compound B- (a) -1. ([ M + H ] ═ 628)
Fig. 16 is a mass spectrum of compound 14 produced in synthesis example 14.
Synthesis example 15 Synthesis of Compound 15
Figure GDA0002886626150001082
Compound 15 (examples 3 to 133) was obtained in the same manner as in Synthesis example 1 except that 2-chloroquinazoline was used in place of 1-bromonaphthalene and that compound B- (c) -1 was used in place of compound B- (a) -1. ([ M + H ] ═ 679)
Fig. 17 is a mass spectrum of compound 15 produced in synthesis example 15.
Synthesis example 16 Synthesis of Compound 16
Figure GDA0002886626150001091
Compound 16 (examples 3 to 56) was obtained in the same manner as in Synthesis example 1, except that 9-bromophenanthrene was used in place of 1-bromonaphthalene and that compound B- (c) -2 was used in place of compound B- (a) -1. ([ M + H ] ═ 693)
Fig. 18 is a mass spectrum of compound 16 produced in synthesis example 16.
Synthesis example 17 Synthesis of Compound 17
Figure GDA0002886626150001092
Compound 17 (examples 3 to 62) was obtained in the same manner as in Synthesis example 1 except that 4-chloropyridine was used in place of 1-bromonaphthalene and Compound B- (c) -2 was used in place of Compound B- (a) -1. ([ M + H ] ═ 595)
Fig. 19 is a mass spectrum of compound 17 produced in synthesis example 17.
Synthesis example 18 Synthesis of Compound 18
Figure GDA0002886626150001101
Compound 18 (examples 3 to 68) was obtained in the same manner as in Synthesis example 1 except that 2-chloro-4, 6-diphenyl-1, 3, 5-triazine was used in place of 1-bromonaphthalene and Compound B- (c) -2 was used in place of Compound B- (a) -1. ([ M + H ] ═ 749)
Fig. 20 is a mass spectrum of compound 18 produced in synthesis example 18.
Synthesis example 19 Synthesis of Compound 19
Figure GDA0002886626150001102
Compound 19 (examples 4 to 37) was obtained in the same manner as in Synthesis example 1, except that 2-bromonaphthalene was used in place of 1-bromonaphthalene and that compound B- (d) -1 was used in place of compound B- (a) -1. ([ M + H ] ═ 693)
Fig. 21 is a mass spectrum of compound 19 produced in synthesis example 19.
Synthesis example 20 Synthesis of Compound 20
Figure GDA0002886626150001111
Compound 20 (examples 4 to 38) was obtained in the same manner as in Synthesis example 1 above, except that 4-bromo-1, 1' -biphenyl was used in place of 1-bromonaphthalene and that compound B- (d) -1 was used in place of compound B- (a) -1. ([ M + H ] ═ 719)
Fig. 22 is a mass spectrum of compound 20 produced in synthesis example 20.
Synthesis example 21 Synthesis of Compound 21
Figure GDA0002886626150001112
Compound 21 (examples 4 to 49) was obtained in the same manner as in Synthesis example 1 above, except that 2-chloro-4-phenylquinazoline was used in place of 1-bromonaphthalene and Compound B- (d) -1 was used in place of Compound B- (a) -1. ([ M + H ] ═ 772)
Fig. 23 is a mass spectrum of compound 21 produced in synthesis example 21.
Synthesis example 22 Synthesis of Compound 22
Figure GDA0002886626150001121
Compound 22 (examples 4 to 157) was obtained in the same manner as in Synthesis example 1 above, except that 4-bromo-1, 1' -biphenyl was used in place of 1-bromonaphthalene and Compound B- (d) -2 was used in place of Compound B- (a) -1. ([ M + H ] ═ 654)
Fig. 24 is a mass spectrum of compound 22 produced in synthesis example 22.
Synthesis example 23 Synthesis of Compound 23
Figure GDA0002886626150001122
Compound 23 (examples 4 to 162) was obtained in the same manner as in Synthesis example 1, except that 2-chloropyridine was used in place of 1-bromonaphthalene and Compound B- (d) -2 was used in place of Compound B- (a) -1. ([ M + H ] ═ 578)
Fig. 25 is a mass spectrum of compound 23 produced in synthesis example 23.
Synthesis example 24 Synthesis of Compound 24
Figure GDA0002886626150001131
Compound 24 (examples 4 to 165) was obtained in the same manner as in Synthesis example 1, except that 2-chloropyrimidine was used in place of 1-bromonaphthalene and that compound B- (d) -2 was used in place of compound B- (a) -1. ([ M + H ] ═ 579)
Fig. 26 is a mass spectrum of compound 24 produced in synthesis example 24.
< production of organic light-emitting device >
Comparative example 1
Will be provided with
Figure GDA0002886626150001132
The glass substrate coated with ITO (indium tin oxide) is put in distilled water in which a dispersant is dissolved, and washed by ultrasonic waves. At this time, the detergent was prepared by Fischer Co, and distilled water was filtered 2 times by using a Filter (Filter) manufactured by Millipore Co. After washing ITO for 30 minutes, ultrasonic washing was performed for 10 minutes by repeating 2 times with distilled water. After the completion of the distilled water washing, the mixture was ultrasonically washed with solvents of isopropyl alcohol, acetone, and methanol, dried, and then transported to a plasma cleaning machine. After the substrate was cleaned with oxygen plasma for 5 minutes, the substrate was transported to a vacuum evaporator.
After the substrate was mounted in the vacuum chamber, the base pressure was set to 1X 10-6torr, organic materials were sequentially deposited on the ITO, that is, DNTPD described below was used as a hole injection and transport layer
Figure GDA0002886626150001133
As the hole transporting and electron blocking layer, the following NPB was used
Figure GDA0002886626150001134
The following CBP, which is generally used as a main material for red phosphorescence in many cases, was used as a main material (95 wt%), and was co-evaporated as a dopant
Figure GDA0002886626150001135
Dp-6(5 wt%) as described above, and Alq as an electron transport layer3
Figure GDA0002886626150001136
LiF is used as the cathode
Figure GDA0002886626150001137
Al
Figure GDA0002886626150001138
And film formation is sequentially performed. In the above process, the evaporation speed of the organic material is maintained
Figure GDA0002886626150001139
Maintenance of LiF
Figure GDA00028866261500011310
Deposition rate of (3), aluminum maintenance
Figure GDA00028866261500011311
The deposition rate of (3).
Figure GDA0002886626150001141
Comparative examples 2 to 8
An organic light-emitting element was produced in the same manner as in comparative example 1, except that the following compounds a to G were used instead of the CBP.
Figure GDA0002886626150001142
Examples 1 to 24
An organic light-emitting element was produced in the same manner as in comparative example 1, except that the compounds 1 to 24 produced in synthesis examples 1 to 24 were used instead of the CBP.
To the organic light emitting elements fabricated in the above comparative examples 1 to 8 and examples 1 to 24, 10mA/cm was applied2And the driving voltage, current efficiency and life were measured, and T95 represents the time required for the luminance to decrease from the initial luminance to 95%. The results are shown in table 1 below.
[ Table 1]
Figure GDA0002886626150001161
In table 1, comparative example 1 is an organic light-emitting element using CBP as a conventional light-emitting layer host material, and comparative examples 2 and 3 are organic light-emitting elements using a compound of chemical formula 2 bonded to R1 and R2 of chemical formula 1 as a host material of a light-emitting layer.
In addition, comparative examples 4 and 5 are organic light-emitting elements using a compound in which carbazole is bonded at the Y1 position in chemical formula 1 of the present application, and comparative examples 6 to 8 are organic light-emitting elements using, as a host material of a light-emitting layer, a compound in which a substituted aryl group is bonded at the Y3 position in chemical formula 1 of the present application, instead of indolocarbazole.
The organic light-emitting elements of embodiments 1 to 24 are those in which indolocarbazoles are bonded to the Y2 or Y3 position in chemical formula 1 of the present application, that is, compounds formed by bonding chemical formula 2 to R2 and R3, or R3 and R4 in chemical formula 1 are used as host materials of the light-emitting layer.
It is understood that the heterocyclic compound of chemical formula 1 of the present application has smooth intramolecular electron flow, less steric hindrance, and stable structure, and therefore the organic light-emitting devices of examples 1 to 24 using the same have lower driving voltage, superior efficiency, and longer life than the organic light-emitting devices of comparative examples 1 to 8.

Claims (5)

1. A heterocyclic compound represented by the following chemical formula 1:
chemical formula 1
Figure FDA0002886626140000011
In the chemical formula 1, the metal oxide is represented by,
x1 is O or S, and X1 is O or S,
l1 is a direct bond that is,
y1 and Y3 are N, Y2 is CR13 and Y4 is CR14, or Y2 and Y4 are N, Y1 is CR14 and Y3 is CR13,
said R13 is a group binding to said L1, R14 is phenyl or naphthyl,
r2 and R3, or R3 and R4 are groups bound to the atom of the following chemical formula 2,
the group not bonded to x of the following chemical formula 2 among R2 to R4, R1 and R5 to R12 are hydrogen,
n is a number of 1, and n is,
chemical formula 2
Figure FDA0002886626140000012
In the chemical formula 2, the first and second organic solvents,
is a site binding to R2 and R3, or R3 and R4 of said chemical formula 1,
ar1 is phenyl, biphenyl, naphthyl, phenanthryl, fluoranthenyl, triphenylenyl, pyrenyl, pyridyl, pyrimidyl, triazinyl substituted by phenyl, or quinazolinyl substituted or unsubstituted by phenyl or naphthyl,
r15 to R18 are hydrogen.
2. The heterocyclic compound according to claim 1, wherein the chemical formula 1 is represented by any one of the following chemical formulae 1-1 to 1-4:
chemical formula 1-1
Figure FDA0002886626140000021
Chemical formula 1-2
Figure FDA0002886626140000022
Chemical formulas 1 to 3
Figure FDA0002886626140000031
Chemical formulas 1 to 4
Figure FDA0002886626140000032
In the chemical formulas 1-1 to 1-4,
x1, L1, n, Y1 to Y4, R1, R2 and R4 to R12 are the same as defined in said chemical formula 1,
ar1 and R15 to R18 are as defined in the chemical formula 2.
3. The heterocyclic compound according to claim 1, wherein the chemical formula 1 is represented by any one of the following chemical formulae 1-5 to 1-12:
chemical formulas 1 to 5
Figure FDA0002886626140000041
Chemical formulas 1 to 6
Figure FDA0002886626140000042
Chemical formulas 1 to 7
Figure FDA0002886626140000051
Chemical formulas 1 to 8
Figure FDA0002886626140000052
Chemical formulas 1 to 9
Figure FDA0002886626140000061
Chemical formulas 1 to 10
Figure FDA0002886626140000062
Chemical formulas 1 to 11
Figure FDA0002886626140000071
Chemical formulas 1 to 12
Figure FDA0002886626140000072
In the chemical formulas 1-5 to 1-12,
x1, L1, n, R1, R2 and R4 to R12 are the same as defined in said chemical formula 1,
ar1 and R15 to R18 are as defined in the chemical formula 2,
r14 is phenyl or naphthyl.
4. The heterocyclic compound according to claim 1, wherein the compound of formula 1 is selected from the following compounds:
Figure FDA0002886626140000081
Figure FDA0002886626140000091
Figure FDA0002886626140000101
Figure FDA0002886626140000111
Figure FDA0002886626140000121
Figure FDA0002886626140000131
Figure FDA0002886626140000141
Figure FDA0002886626140000151
Figure FDA0002886626140000161
Figure FDA0002886626140000171
Figure FDA0002886626140000181
Figure FDA0002886626140000191
Figure FDA0002886626140000201
Figure FDA0002886626140000211
Figure FDA0002886626140000221
Figure FDA0002886626140000231
Figure FDA0002886626140000241
Figure FDA0002886626140000251
Figure FDA0002886626140000261
Figure FDA0002886626140000271
Figure FDA0002886626140000281
Figure FDA0002886626140000291
Figure FDA0002886626140000301
Figure FDA0002886626140000311
Figure FDA0002886626140000321
Figure FDA0002886626140000331
Figure FDA0002886626140000341
Figure FDA0002886626140000351
Figure FDA0002886626140000361
Figure FDA0002886626140000371
Figure FDA0002886626140000381
Figure FDA0002886626140000391
Figure FDA0002886626140000401
Figure FDA0002886626140000411
Figure FDA0002886626140000421
Figure FDA0002886626140000431
Figure FDA0002886626140000441
Figure FDA0002886626140000451
Figure FDA0002886626140000461
Figure FDA0002886626140000471
Figure FDA0002886626140000481
Figure FDA0002886626140000491
Figure FDA0002886626140000501
Figure FDA0002886626140000511
Figure FDA0002886626140000521
Figure FDA0002886626140000531
Figure FDA0002886626140000541
Figure FDA0002886626140000551
Figure FDA0002886626140000561
Figure FDA0002886626140000571
Figure FDA0002886626140000581
Figure FDA0002886626140000591
Figure FDA0002886626140000601
Figure FDA0002886626140000611
5. an organic light-emitting element comprising: a first electrode, a second electrode provided so as to face the first electrode, and 1 or more organic layers provided between the first electrode and the second electrode, wherein 1 or more of the organic layers contain the heterocyclic compound according to any one of claims 1 to 4, and wherein the organic layer contains a light-emitting layer containing the heterocyclic compound.
CN201880002765.5A 2017-02-14 2018-02-12 Heterocyclic compound and organic light-emitting element comprising same Active CN109476678B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2017-0019961 2017-02-14
KR20170019961 2017-02-14
PCT/KR2018/001809 WO2018151479A2 (en) 2017-02-14 2018-02-12 Heterocyclic compound and organic light emitting element comprising same

Publications (2)

Publication Number Publication Date
CN109476678A CN109476678A (en) 2019-03-15
CN109476678B true CN109476678B (en) 2021-06-01

Family

ID=63169862

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880002765.5A Active CN109476678B (en) 2017-02-14 2018-02-12 Heterocyclic compound and organic light-emitting element comprising same

Country Status (3)

Country Link
KR (1) KR102056535B1 (en)
CN (1) CN109476678B (en)
WO (1) WO2018151479A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111072666A (en) * 2018-10-19 2020-04-28 北京鼎材科技有限公司 Organic electroluminescent material and application thereof
CN112218861B (en) * 2018-10-22 2023-08-04 株式会社Lg化学 Polycyclic compound and organic light-emitting element including the same
CN109970716B (en) * 2019-04-11 2020-07-24 石家庄诚志永华显示材料有限公司 Organic compound and application thereof in organic electroluminescent device
WO2020226280A1 (en) * 2019-05-03 2020-11-12 주식회사 엘지화학 Heterocyclic compound and organic light-emitting device comprising same
KR20230133787A (en) * 2022-03-11 2023-09-19 에스에프씨 주식회사 Organic compounds and organic light-emitting device comprising the same

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160293853A1 (en) * 2015-04-06 2016-10-06 Universal Display Corporation Organic Electroluminescent Materials and Devices

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10135513B4 (en) 2001-07-20 2005-02-24 Novaled Gmbh Light-emitting component with organic layers
KR102081689B1 (en) * 2013-03-15 2020-02-26 덕산네오룩스 주식회사 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof
KR102140018B1 (en) * 2013-12-17 2020-07-31 삼성전자주식회사 Condensed cyclic compound and organic light emitting device including the same
KR102377221B1 (en) * 2015-01-20 2022-03-22 에스에프씨주식회사 Novel heterocyclic compounds and organic light-emitting diode including the same
US11495749B2 (en) * 2015-04-06 2022-11-08 Universal Display Corporation Organic electroluminescent materials and devices

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160293853A1 (en) * 2015-04-06 2016-10-06 Universal Display Corporation Organic Electroluminescent Materials and Devices

Also Published As

Publication number Publication date
WO2018151479A2 (en) 2018-08-23
KR102056535B1 (en) 2019-12-16
WO2018151479A3 (en) 2018-12-06
CN109476678A (en) 2019-03-15
KR20180093819A (en) 2018-08-22

Similar Documents

Publication Publication Date Title
CN109075261B (en) Organic light emitting device
KR101737199B1 (en) Hetero-cyclic compound and organic light emitting device comprising the same
CN107614494B (en) Spiro compound and organic light emitting device including the same
CN107619410B (en) Compound and organic electronic element comprising same
CN109476678B (en) Heterocyclic compound and organic light-emitting element comprising same
KR20200063053A (en) Novel compound and organic light emitting device comprising the same
CN107868067B (en) Heterocyclic compound and organic light-emitting element comprising same
CN107698601B (en) Heterocyclic compound and organic electroluminescent element comprising same
KR102506584B1 (en) Novel compound and organic light emitting device comprising the same
KR20170057856A (en) Compound having spiro structure and organic light emitting device comprising the same
CN107108407B (en) Spiro-cyclic compound and organic light emitting device including the same
KR102136381B1 (en) Novel hetero-cyclic compound and organic light emitting device comprising the same
KR101878544B1 (en) Hetero-cyclic compound and organic light emitting device comprising the same
EP3862350A1 (en) Novel compound and organic light emitting device using same
KR102562354B1 (en) Novel compound and organic light emitting device comprising the same
CN107257787B (en) Heterocyclic compound and organic light-emitting element comprising same
KR20170057855A (en) Compound having spiro structure and organic light emitting device comprising the same
CN111417631A (en) Polycyclic compound and organic light-emitting element comprising same
CN113874366A (en) Heterocyclic compound and organic light emitting device including the same
CN113287211A (en) Organic light emitting device
KR102592082B1 (en) Novel compound and organic light emitting device comprising the same
KR20200057648A (en) Novel compound and organic light emitting device comprising the same
KR102469106B1 (en) Novel compound and organic light emitting device comprising the same
CN111386262A (en) Heterocyclic compound and organic light emitting device including the same
KR20200078156A (en) Novel compound and organic light emitting device comprising the same

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant